Virion Therapeutics
Latest round
- Angel
Last raised
- Sep 2018
Total raised
- $4M
Investors
- 6
About Virion Therapeutics
Virion Therapeutics, LLC, founded in 2018 and headquartered in Newark, US, focuses on T cell-based immunotherapies.05 mn.Virion Therapeutics specializes in developing innovative T cell-based immunotherapies aimed at treating cancer and chronic infectious diseases. Central to their offerings is the use of genetically encoded checkpoint modifiers (CPMs) that enhance and broaden CD8+ T cell responses. Their lead product, VRON-0200, is currently in the first-in-human study phase, with enrollment initiated in Q3 2023.Virion Therapeutics generates revenue through clinical trials and partnerships with healthcare institutions, collaborating with research hospitals and clinical trial networks. Their revenue structure is based on research agreements or grants, with potential future sales of approved therapies.Virion Therapeutics plans to advance its product pipeline with VRON-0200 expected to enter the market following successful clinical trials.25 mn will support these initiatives and aid in expanding their operations into targeted markets across North America and Europe. The company is focused on enhancing its clinical trial capabilities and securing additional partnerships to facilitate growth.
Who invested in Virion Therapeutics
6 investors across 1 round
See all investors in Virion Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Sep 4, 2018
Amount
$4M
Investors
Questions about Virion Therapeutics
Who invested in Virion Therapeutics?
Virion Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Virion Therapeutics raised?
Virion Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Virion Therapeutics last raise money?
Virion Therapeutics's most recent round on record is a Angel, in Sep 2018.
What does Virion Therapeutics do?
Virion Therapeutics, LLC, founded in 2018 and headquartered in Newark, US, focuses on T cell-based immunotherapies.
Where is Virion Therapeutics headquartered?
Virion Therapeutics is headquartered in Newark, US.
Which VCs invest in companies like Virion Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Virion Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Virion Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.